Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | CCR6 | P51684 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11052544 | 0.81 | ALDH1A1 (0.44) | ALDH1A1HTTLMNAKMT2AHSP90AA1 | |
| SCHEMBL28171848 | 0.80 | KMT2A (0.61) | ALDH1A1HTTLMNAKMT2AHSP90AA1 | |
| SCHEMBL8678075 | 0.78 | HSP90AA1 (1.00) | ALDH1A1HTTLMNAKMT2AHSP90AA1 | |
| SCHEMBL10929737 | 0.77 | RAD51 (0.45) | ALDH1A1HTTLMNAKMT2AMEN1 | |
| SCHEMBL10834058 | 0.76 | MAPT (0.67) | ALDH1A1HTTLMNAKMT2AHPGD | |
| SCHEMBL6253484 | 0.75 | MAPT (0.44) | ALDH1A1HTTLMNAKMT2AHPGD | |
| SCHEMBL11638382 | 0.73 | MGLL (0.62) | ALDH1A1HTTLMNAKMT2AHPGD | |
| Fluoroimide SCHEMBL68964 | 0.72 | MGLL (0.56) | KMT2AMEN1GAA | |
| SCHEMBL8504879 | 0.72 | MEN1 (0.65) | ALDH1A1KMT2AMEN1MAPTSMN1; SMN2 | |
| SCHEMBL6211924 | 0.71 | ALDH1A1 (0.54) | ALDH1A1HTTLMNAKMT2AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 761 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391729-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2025-08-19 | — | — | US | claimed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | claimed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-20210179672-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2021-06-17 | — | — | US | claimed |
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2016044655-A2 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-20130195997-A1 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2533633-A2 | FUNGICIDAL MIXTURES | LANXESS Distribution GmbH (DE) | 2012-12-19 | — | — | EP | claimed |
| EP-2460408-A1 | Nematicidal compositions | deVGen N.V. (BE) | 2012-06-06 | — | — | EP | claimed |
| US-20110319435-A1 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-12-29 | — | — | US | claimed |
| WO-2011095492-A2 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-08-11 | — | — | WO | claimed |
| EP-2315522-A2 | FORMATE-CONTAINING FUNGICIDE MIXTURES | LANXESS Distribution GmbH (DE) | 2011-05-04 | — | — | EP | claimed |
| EP-2153720-A1 | Fungicide mixtures comprising formate | LANXESS Distribution GmbH (DE) | 2010-02-17 | — | — | EP | claimed |
| WO-2010015635-A2 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2010-02-11 | — | — | WO | claimed |
| US-4455315-A | N-(Difluoromethoxy substituted phenyl)-dichloromaleimides used in agricultural and horticultural fungicidal methods | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1984-06-19 | — | — | US | claimed |
| US-12630484-B2 | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes | SPOGEN BIOTECH INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-12599649-B2 | Bioactive polypeptides for improvements in plant protection, growth and productivity | SPOGEN BIOTECH INC. (US) | 2026-04-14 | — | — | US | disclosed |
| WO-1997047606-A1 | ARYLOXYACRYLIC ACID ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-18 | — | — | WO | disclosed |
| WO-1997008135-A1 | ACYLAMINOSALICYLIC ACID AMIDES AND THEIR USES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |
| US-4455315-A | N-(Difluoromethoxy substituted phenyl)-dichloromaleimides used in agricultural and horticultural fungicidal methods | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1984-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630484-B2 | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes | ADA, RNGTT, GNPDA1 | ALDH1A1 2323/4885HTT 4654/4885LMNA 3510/4885 |
| US-12599649-B2 | Bioactive polypeptides for improvements in plant protection, growth and productivity | MAX, VIP, MRTO4 | ALDH1A1 4854/4885HTT 1556/4885LMNA 1747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.